CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Modifiable lifestyle factors and heart failure: A Mendelian randomization study Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Primary Prevention of Heart Failure in Women How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Heart Failure and Atrial Fibrillation, Like Fire and Fury Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial
|<<... 7 8 9 10 11 12 13 ...>>|

Original ResearchVolume 73, Issue 18, 14 May 2019, Pages 2267-2282

JOURNAL：J Am Coll Cardiol. Article Link

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure

CK Nagaraju, EL Robinson, KR Sipido et al. Keywords: contractile function extracellular matrix fibroblasts inflammation

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top